April - June 2017, Volume 13, Issue 2

Gafencu M, Bizerea TO, Stroescu RF, Costa R, Marginean O, Doros G

Thyroid Dysfunction in an AIDS Patient

Acta Endo (Buc) 2017, 13 (2): 220-223
doi: 10.4183/aeb.2017.220

Objective. Highly active antiretroviral therapy (HAART) is involved in the potential pathogenic mechanisms linking thyroid autoimmunity with immune restoration. The objective is to emphasize the emergence of autoimmune thyroid disease in a HIV patient long period after restoration of immune competence, unlinked to the immune reconstitution inflammatory syndrome (IRIS) occurring shortly after HAART initiation. We report a case of acute autoimmune thyroiditis with thyrotoxicosis in a patient with stage C3 HIV infection, who had been under HAART for more than 7 years. From the beginning there was a good immune response to the regimen, due to a good adherence and compliance (over 90%). Nine months after HAART initiation the viral load was undetectable (under 34 copies/μL) and the CD4 count reached 645 cells/mm3 (within normal range) after one year of treatment. Eight years after HAART initiation, based on clinical and laboratory findings, autoimmune thyroiditis was diagnosed. At this time immune competence with a normal CD4 count and a CD4/CD8 ratio over 1 was achieved. The chronic inflammation status of an HIV infection is the reason that autoimmunity appears outside the IRIS period. Treatment was initiated with antithyroid drugs. Thyroid function should be monitored periodically in HIV patients undergoing HAART. Future observations must be made for HIV related thyroid disorders using new classifications and studies with a larger number of patients.

Keywords: HIV, autoimmune thyroiditis, HAART.

Correspondence: Teofana Otilia Bizerea, “Louis Turcanu” Children’s Clinical and Emergency Hospital, Dept. of Pediatrics, 2, I. Nemoianu Street, Timi?oara, 300011, Romania, E-mail: teofanabizerea@yahoo.com